For its fourth fiscal quarter (ending September 30), Hologic Inc (NASDAQ: HOLX) has reported a 105% increase in E.P.S. from $0.37 a year ago to $0.76 in the current quarter. For the latest four quarters through September 30, E.P.S. were $3.35 compared to $1.85 a year ago — an increase of 81%.
Recent Price Action
Hologic Inc (NASDAQ: HOLX) stock closed at $83.72 on 11/4/24 after an increase of 1.7%. Moreover, exceptionally high trading volume at 242% of normal accompanied the advance. Relative to the market the stock has been strong over the last nine months and has risen 3.6% during the last week.
Current PriceTarget Research Rating
HOLX is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Hologic has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Hologic has a poor Appreciation Score of 29 but a neutral Power Rating of 55, producing the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment